BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29653486)

  • 1. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
    Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
    Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
    Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
    PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
    Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
    PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergic effect of PD-1 blockade and endostar on the PI3K/AKT/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model.
    Wu J; Zhao X; Sun Q; Jiang Y; Zhang W; Luo J; Li Y
    Biomed Pharmacother; 2020 May; 125():109746. PubMed ID: 32106386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma.
    Huang G; Chen L
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1201-11. PubMed ID: 20130910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model.
    Jia Y; Liu M; Cao L; Zhao X; Wu J; Lu F; Li Y; He Y; Ren S; Ju Y; Wang Y; Li Z
    Eur J Gynaecol Oncol; 2011; 32(3):316-24. PubMed ID: 21797125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.
    Wang R; Qin S; Chen Y; Li Y; Chen C; Wang Z; Zheng R; Wu Q
    Oncol Rep; 2012 Aug; 28(2):439-45. PubMed ID: 22641525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
    Roberts WG; Whalen PM; Soderstrom E; Moraski G; Lyssikatos JP; Wang HF; Cooper B; Baker DA; Savage D; Dalvie D; Atherton JA; Ralston S; Szewc R; Kath JC; Lin J; Soderstrom C; Tkalcevic G; Cohen BD; Pollack V; Barth W; Hungerford W; Ung E
    Cancer Res; 2005 Feb; 65(3):957-66. PubMed ID: 15705896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostar combined with cisplatin inhibits tumor growth and lymphatic metastasis of lewis lung carcinoma xenografts in mice.
    Dong XP; Xiao TH; Dong H; Jiang N; Zhao XG
    Asian Pac J Cancer Prev; 2013; 14(5):3079-83. PubMed ID: 23803083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
    Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
    J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.
    Wu H; Deng J; Yu S; Wang X; Chen Y
    J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):108-12. PubMed ID: 20155466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
    Keskin D; Kim J; Cooke VG; Wu CC; Sugimoto H; Gu C; De Palma M; Kalluri R; LeBleu VS
    Cell Rep; 2015 Feb; 10(7):1066-81. PubMed ID: 25704811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
    Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of rh-endostar in combination with radiotherapy on rats with lung cancer].
    Du H; Ge W; Li C; Zhao Z; Xu X; Yang F
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):386-90. PubMed ID: 20677570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.
    Wen QL; Meng MB; Yang B; Tu LL; Jia L; Zhou L; Xu Y; Lu Y
    Cancer Sci; 2009 Aug; 100(8):1510-9. PubMed ID: 19459845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.
    Lu C; Shahzad MM; Moreno-Smith M; Lin YG; Jennings NB; Allen JK; Landen CN; Mangala LS; Armaiz-Pena GN; Schmandt R; Nick AM; Stone RL; Jaffe RB; Coleman RL; Sood AK
    Cancer Biol Ther; 2010 Feb; 9(3):176-82. PubMed ID: 20009575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β.
    Zhou L; Sun X; Huang Z; Zhou T; Zhu X; Liu Y; Wang J; Cheng B; Li M; He C; Liu X
    Cell Physiol Biochem; 2018; 48(1):263-273. PubMed ID: 30007969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.
    Jia Y; Liu M; Huang W; Wang Z; He Y; Wu J; Ren S; Ju Y; Geng R; Li Z
    Pathol Oncol Res; 2012 Apr; 18(2):315-23. PubMed ID: 21938482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
    Iesato A; Li S; Roti G; Hacker MR; Fischer AH; Nucera C
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3569-3590. PubMed ID: 34302727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
    Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
    FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.